PCM
TRIL

Prelude Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Prelude Capital Management’s Portfolio TRIL Stock Details TRIL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
2021
Q3 		$430K Buy
2017
Q3 		– Sell
2017
Q2 		$131K Buy
2017
Q1 		$145K Hold
2016
Q4 		$133K Buy
2016
Q3 		$6K Buy
2016
Q2 		$2K Buy